Furiex Pharmaceuticals Inc (FURX) financial statements (2022 and earlier)

Company profile

Business Address 3900 PARAMOUNT PARKWAY
MORRISVILLE, NC 27560
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments29,15325,718
Cash and cash equivalents29,15325,718
Receivables8,17811,745
Prepaid expense415
Prepaid expense and other current assets320
Total current assets:37,74637,783
Noncurrent Assets
Property, plant and equipment87118
Intangible assets, net (including goodwill)49,11649,116
Goodwill49,11649,116
Restricted cash and investments 7,500
Deferred costs1,493238
Total noncurrent assets:50,69656,972
TOTAL ASSETS:88,44294,755
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,37416,834
Accounts payable7,0726,604
Accrued liabilities5,30210,230
Debt10,0805,405
Due to related parties500 
Total current liabilities:22,95422,239
Noncurrent Liabilities
Long-term debt and lease obligation31,92034,595
Long-term debt, excluding current maturities31,92034,595
Liabilities, other than long-term debt15,127104
Deferred tax liabilities, net (220)
Due to related parties14,500 
Other liabilities627324
Other undisclosed noncurrent liabilities 220
Total noncurrent liabilities:47,04734,919
Total liabilities:70,00157,158
Stockholders' equity
Stockholders' equity attributable to parent18,44137,597
Common stock1010
Additional paid in capital175,094164,577
Accumulated deficit(156,663)(126,990)
Total stockholders' equity:18,44137,597
TOTAL LIABILITIES AND EQUITY:88,44294,755

Income statement (P&L) ($ in thousands)

12/31/2013
12/31/2012
Revenues
(Revenue, Net)
70,99940,508
Gross profit:70,99940,508
Operating expenses(95,437)(80,852)
Operating loss:(24,438)(40,344)
Nonoperating income
(Other Nonoperating income)
931
Interest and debt expense(4,980)(2,508)
Loss from continuing operations before income taxes:(29,325)(42,851)
Income tax expense(348)(14)
Net loss available to common stockholders, diluted:(29,673)(42,865)

Comprehensive Income ($ in thousands)

12/31/2013
12/31/2012
Net loss:(29,673)(42,865)
Comprehensive loss, net of tax, attributable to parent:(29,673)(42,865)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: